Gennex Laboratories Ltd

Business Update

Gennex Laboratories Business Update

Subsidiary Deccan Remedies Ltd received approvals from the Drug Control Administration, Andhra Pradesh, to manufacture ten additional pharmaceutical products and test licences at its facility.

Annual General Meeting

Gennex Laboratories Annual General Meeting

Gennex Laboratories Limited announced the closure of its register of members from September 23 to September 30, 2026. This is for the upcoming 41st Annual General Meeting.

Board Meeting Outcome

Gennex Laboratories Board Meeting Outcome

Gennex Laboratories announced the outcome of its board meeting, approving the draft directors' report and scheduling the 41st Annual General Meeting for September 30, 2026.

Financial Results

Gennex Laboratories Q1 FY27 Results: Net Profit ₹4.7 Cr, Down 6.0% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹39.8 Cr (+16.4% YoY) and net profit of ₹4.7 Cr (-6.0% YoY) for Q1 FY27.

Key figure

Net profit ₹4.7 Cr · -6.0% YoY

Financial Results

Gennex Laboratories Q4 FY26 Results: Net Profit ₹4.5 Cr, Up 45.2% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹61 Cr (+51.4% YoY) and net profit of ₹4.5 Cr (+45.2% YoY) for Q4 FY26.

Key figure

Net profit ₹4.5 Cr · +45.2% YoY